No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs541319487 |
chr7:3185995-3185996 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs555268714 |
chr7:3185998-3185999 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs570816722 |
chr7:3186006-3186007 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs575054776 |
chr7:3186009-3186010 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs544017992 |
chr7:3186084-3186085 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs563898559 |
chr7:3186086-3186087 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs532240023 |
chr7:3186101-3186102 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs569602503 |
chr7:3186113-3186114 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs189069147 |
chr7:3186114-3186115 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs528092250 |
chr7:3186143-3186144 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs74608790 |
chr7:3186151-3186152 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs568029391 |
chr7:3186191-3186192 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs550293388 |
chr7:3186193-3186194 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs73672268 |
chr7:3186247-3186248 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs376829195 |
chr7:3186258-3186259 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs148836877 |
chr7:3186268-3186269 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs559015410 |
chr7:3186277-3186278 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs565910902 |
chr7:3186293-3186294 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs535034834 |
chr7:3186296-3186297 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs555038658 |
chr7:3186320-3186321 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs575162150 |
chr7:3186337-3186338 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs544172241 |
chr7:3186348-3186349 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs200000856 |
chr7:3186369-3186370 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs386709431 |
chr7:3186370-3186371 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs557577032 |
chr7:3186372-3186373 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs535655384 |
chr7:3186416-3186417 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs374247072 |
chr7:3186425-3186426 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs554315418 |
chr7:3186477-3186478 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs180937660 |
chr7:3186480-3186481 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs79478477 |
chr7:3186493-3186494 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs528039298 |
chr7:3186502-3186503 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs117123236 |
chr7:3186503-3186504 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs561394229 |
chr7:3186506-3186507 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs12534973 |
chr7:3186510-3186511 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs12531776 |
chr7:3186513-3186514 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
36 |
rs548454465 |
chr7:3186580-3186581 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs73037728 |
chr7:3186597-3186598 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
38 |
rs533176398 |
chr7:3186610-3186611 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs185460394 |
chr7:3186613-3186614 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs566150350 |
chr7:3186622-3186623 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs534836280 |
chr7:3186629-3186630 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs572452615 |
chr7:3186636-3186637 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs369295221 |
chr7:3186638-3186639 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs568505227 |
chr7:3186657-3186658 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs143441802 |
chr7:3186669-3186670 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs575631664 |
chr7:3186695-3186696 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs557689590 |
chr7:3186701-3186702 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs543143685 |
chr7:3186746-3186747 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs540037693 |
chr7:3186751-3186752 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs138159367 |
chr7:3186752-3186753 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|